Ioanna Bezirtzoglou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ioanna Bezirtzoglou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Christina Tsigalou
Master Program in “Food, Nutrition and Microbiome”, Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece
3 shared publications - Elisavet Stavropoulou
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
3 shared publications - Christos Stefanis
Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece
2 shared publications - Agathangelos Stavropoulos
Master Program in “Food, Nutrition and Microbiome”, Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece
1 shared publication - Chrissoula Voidarou
Department of Agriculture, School of Agriculture, University of Ioannina, 47100 Arta, Greece
1 shared publication - Christos G. Nikolaidis
Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical School, ‘AHEPA’ University General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication
Latest Publications
- Open Access
Are Human and LLM-Generated Observations Statistically Comparable? Rethinking Sampling Units, Variability, and Statistical Inference
The increasing use of Large Language Models (LLMs) as synthetic respondents, experimental participants, or comparators to human samples and populations raises a critical statistical question: under what conditions can LLM-generated observations support valid inductive reasoning alongside human data? This paper distinguishes between the heterogeneity inherent in human populations and the algorithmic variability of LLMs, emphasising that similarity in observed responses does not necessarily indicate equivalence in the underlying generative processes. Human data are derived from individuals sampled from a target population. In contrast, repeated LLM responses are generated by a probabilistic computational system, with variability influenced by the model, prompt, production parameters, context, repeated runs, and computational environment. Consequently, the nominal number of LLM-generated responses should not be equated with an equivalent number of independent human sampling units. This distinction affects the independence of observations, repeatability, sample size, statistical testing, and the interpretation of human–LLM comparisons. Conventional statistical methods are not inherently unsuitable for LLM-generated data; however, their validity depends on whether the experimental unit, estimand, dependency structure, and methodological assumptions align with the data-generating process. To support practical application, a six-stage methodological framework is proposed: defining the inference goal, identifying units and data-generation processes, assessing replication, validating human–LLM comparability, selecting appropriate statistical analyses, and evaluating the sensitivity, reproducibility, and scope of inference. Human–LLM comparability should be treated as an empirical, estimand-specific property rather than assumed from equal sample sizes, similar means, non-significant differences, or the application of identical statistical tests.
Open AccessAre Human and LLM-Generated Observations Statistically Comparable? Rethinking Sampling Units, Variability, and Statistical Inference
The increasing use of Large Language Models (LLMs) as synthetic respondents, experimental participants, or comparators to human samples and populations raises a critical statistical question: under what conditions can LLM-generated observations support valid inductive reasoning alongside human data? This paper distinguishes between the heterogeneity inherent in human populations and the algorithmic variability of LLMs, emphasising that similarity in observed responses does not necessarily indicate equivalence in the underlying generative processes. Human data are derived from individuals sampled from a target population. In contrast, repeated LLM responses are generated by a probabilistic computational system, with variability influenced by the model, prompt, production parameters, context, repeated runs, and computational environment. Consequently, the nominal number of LLM-generated responses should not be equated with an equivalent number of independent human sampling units. This distinction affects the independence of observations, repeatability, sample size, statistical testing, and the interpretation of human–LLM comparisons. Conventional statistical methods are not inherently unsuitable for LLM-generated data; however, their validity depends on whether the experimental unit, estimand, dependency structure, and methodological assumptions align with the data-generating process. To support practical application, a six-stage methodological framework is proposed: defining the inference goal, identifying units and data-generation processes, assessing replication, validating human–LLM comparability, selecting appropriate statistical analyses, and evaluating the sensitivity, reproducibility, and scope of inference. Human–LLM comparability should be treated as an empirical, estimand-specific property rather than assumed from equal sample sizes, similar means, non-significant differences, or the application of identical statistical tests.
- Open Access
- 24 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (4) , 725
Microbiome Research in Greece: A Comprehensive Bibliometric Study
Bibliometric analyses are increasingly used to evaluate scientific domains, revealing research trends, productivity, and impact. This study provides a bibliometric analysis of microbiome-related research conducted by Greek scientists. Data were retrieved from the Scopus database, using the keyword “microbiome” (English) for publications until December 2024. Bibliometric analysis was performed using VOSviewer and the bibliometrix package in R. Our findings indicate that research output has increased exponentially since 2018, with the National and Kapodistrian University of Athens and the Aristotle University of Thessaloniki leading microbiome research in Greece. Medicine, biochemistry, genetics, molecular biology, immunology, and microbiology are the predominant research fields. The keyword analysis highlights “microbiome”, “microbiota”, “probiotics”, “prebiotics”, “intestinal flora”, and “16S rRNA” as central topics. Additionally, we acknowledge the role played by alternative microbial markers, including 18S rRNA/ITS sequencing, for fungal diversity studies. This bibliometric study demonstrates a dynamic and evolving research landscape in Greece and highlights the international relevance of Greek contributions to microbiome science.
- 24 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (4) , 725
Open AccessMicrobiome Research in Greece: A Comprehensive Bibliometric Study
Bibliometric analyses are increasingly used to evaluate scientific domains, revealing research trends, productivity, and impact. This study provides a bibliometric analysis of microbiome-related research conducted by Greek scientists. Data were retrieved from the Scopus database, using the keyword “microbiome” (English) for publications until December 2024. Bibliometric analysis was performed using VOSviewer and the bibliometrix package in R. Our findings indicate that research output has increased exponentially since 2018, with the National and Kapodistrian University of Athens and the Aristotle University of Thessaloniki leading microbiome research in Greece. Medicine, biochemistry, genetics, molecular biology, immunology, and microbiology are the predominant research fields. The keyword analysis highlights “microbiome”, “microbiota”, “probiotics”, “prebiotics”, “intestinal flora”, and “16S rRNA” as central topics. Additionally, we acknowledge the role played by alternative microbial markers, including 18S rRNA/ITS sequencing, for fungal diversity studies. This bibliometric study demonstrates a dynamic and evolving research landscape in Greece and highlights the international relevance of Greek contributions to microbiome science.
- Open Access
- 11 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 507
Exploring the Gut Microbiome’s Role in Inflammatory Bowel Disease: Insights and Interventions
Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory condition of the intestine that significantly impairs quality of life and imposes a heavy burden on healthcare systems globally. While the exact etiology of IBD is unclear, it is influenced by genetic, environmental, immunological, and microbial factors. Recent advances highlight the gut microbiome’s pivotal role in IBD pathogenesis. The microbial dysbiosis characteristic of IBD, marked by a decline in beneficial bacteria and an increase in pathogenic microbes, suggests a profound connection between microbial imbalance and disease mechanisms. This review explores diagnostic approaches to IBD that integrate clinical assessment with advanced microbiological analyses, highlighting the potential of microbiome profiling as a non-invasive diagnostic tool. In addition, it evaluates conventional and emerging treatments and discusses microbiome-targeted intervention prospects, such as probiotics, symbiotics, and faecal microbiota transplantation. The necessity for future research to establish their efficacy and safety is emphasised.
- 11 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 507
Open AccessExploring the Gut Microbiome’s Role in Inflammatory Bowel Disease: Insights and Interventions
Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory condition of the intestine that significantly impairs quality of life and imposes a heavy burden on healthcare systems globally. While the exact etiology of IBD is unclear, it is influenced by genetic, environmental, immunological, and microbial factors. Recent advances highlight the gut microbiome’s pivotal role in IBD pathogenesis. The microbial dysbiosis characteristic of IBD, marked by a decline in beneficial bacteria and an increase in pathogenic microbes, suggests a profound connection between microbial imbalance and disease mechanisms. This review explores diagnostic approaches to IBD that integrate clinical assessment with advanced microbiological analyses, highlighting the potential of microbiome profiling as a non-invasive diagnostic tool. In addition, it evaluates conventional and emerging treatments and discusses microbiome-targeted intervention prospects, such as probiotics, symbiotics, and faecal microbiota transplantation. The necessity for future research to establish their efficacy and safety is emphasised.